Joslin

JDRF Announces the Appointment of David M. Harlan, MD, as Director of the JDRF Center of Excellence in New England

Retrieved on: 
Thursday, June 16, 2022
Biomedical Research, Doctor of Philosophy, Harvard University, Joslin, Education, Industry, T1D, JDRF, Medical school, Harvard Medical School, School, Jackson Laboratory, News, National Cancer Institute, Efficiency, Research, University of Massachusetts, Hospital, Disease, University of Massachusetts Medical School, Alvin J. Siteman Cancer Center, U.S. News & World Report, University, Health, Volunteering, Biomedical sciences, Joslin Diabetes Center, Twitter, HSCI, Diabetes, Multimedia, NIH, Pharmaceutical industry, MD, Facebook, Instagram

To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception.

Key Points: 
  • To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception.
  • We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D.
  • For more information, please visit jdrf.org or follow us on Twitter (@JDRF), Facebook (@myjdrf), and Instagram (@jdrfhq).
  • UMass Chan Medical School , one of five campuses of the University of Massachusetts system, comprises the T.H.

Joslin Diabetes Center Collaborates with Cecelia Health to Improve Continuous Glucose Monitor (CGM) Adoption Among Older Adults with Diabetes

Retrieved on: 
Tuesday, April 26, 2022
State University of New York Upstate Medical University, Awareness, T1D, Metabolism, Adoption, American Diabetes Association, Longwood Medical Area station, Faculty, Population, Rosalind Franklin University of Medicine and Science, Geriatrics, Research, Health, REST, Joslin Diabetes Center, Element, Education, Diabetes, Patient, Sustainable Development Technology Canada, Life expectancy, Program, Leona, Central, Longwood Medical and Academic Area, Technology, Telehealth, Hypoglycemia, Insurance, CGM, Joslin, Ready, Set, PrEP, Sustainability, LMA, Conditional sentence, Public Health Service Distinguished Service Medal, Critical care, Assistant, The Leona M. and Harry B. Helmsley Charitable Trust, Harvard Medical School, Risk, Quality of life, Pharmaceutical industry, Medical device, Hospital, Helmsley, Medicine, Endocrinology, Science

NEW YORK, April 26, 2022 /PRNewswire-PRWeb/ -- Cecelia Health and Joslin Diabetes Center today announced a collaborative program to address and overcome barriers to the initiation and use of continuous glucose monitoring (CGM) in older adults with diabetes on complex insulin regimens. The study, building on Joslin Diabetes Center's previous work with this patient population, is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.

Key Points: 
  • One of the tools shown to improve glycemic control and reduce risk of hypoglycemia when used appropriately is real-time CGM.
  • This project is a collaboration between the Joslin Diabetes Center teams in Boston, Massachusetts and Syracuse, New York, and Cecelia Health's national remote care team.
  • "This is a tremendous opportunity to partner with Joslin Diabetes Center to support this vulnerable population of older adults on complex diabetes regimens and (potentially) establish a new standard in remote diabetes care.
  • The Joslin Diabetes Center affiliate at SUNY Upstate Medical University, located in Syracuse NY, provides Central NYS communities excellence in patient care, education and research in diabetes.

Cracking the code for a new system of cell-to-cell signaling

Retrieved on: 
Wednesday, December 22, 2021
Exosome, Nervous system, RNA, Communication, Disease, Medicine, Kidney, Tissue (biology), MicroRNA, Behavior, Pancreas, Cell, Joslin Diabetes Center, Buck Institute for Research on Aging, National, Tissue, Diabetes, Collection, Metabolism, Health, Research, Ageing, Brain, Blood, Hormone, Glucose, Liver, MD, Lists of diseases, Kahn, Harvard Medical School, Joslin, Phosphorus, Pharmaceutical industry, Antibiotics, Medical imaging, Nature

We have long known about two routes for cell-to-cell communication: the nervous system and the secretion of hormones.

Key Points: 
  • We have long known about two routes for cell-to-cell communication: the nervous system and the secretion of hormones.
  • These are very short RNAs that can regulate the ability of other longer RNAs that make different cellular proteins and control cell function.
  • "In some cases, microRNAs are 80 times more concentrated in the exosome than they are in the cell," said Kahn.
  • Samah Shah, Sandip Kumar Patel and Birgit Schilling of the Buck Institute for Research on Aging also contributed.

Ascensia Diabetes Care Honored At Joslin Diabetes Center High Hopes "Virtual" Gala

Retrieved on: 
Monday, November 15, 2021
Ames Reflectance Meter, CGM, CONTOUR, Reading, No, Technology, BGM, Blood, Joslin, Joslin Diabetes Center, Partnership, History, Diabetes, Glucose meter, Foundation, Medical device

PARSIPPANY,N.J., Nov. 15, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR blood glucose monitoring (BGM) system portfolio and distributors of the Eversense continuous glucose monitoring (CGM) system, was named as an honoree at the Joslin Diabetes Center High Hopes Gala, to celebrate the 100th Anniversary of Insulin, held on November 13th.

Key Points: 
  • PARSIPPANY,N.J., Nov. 15, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR blood glucose monitoring (BGM) system portfolio and distributors of the Eversense continuous glucose monitoring (CGM) system, was named as an honoree at the Joslin Diabetes Center High Hopes Gala, to celebrate the 100th Anniversary of Insulin, held on November 13th.
  • The event honored the top 100 people, groups, corporations and foundations that Joslin admire and appreciate for their impact on the diabetes community.
  • Throughout the organization's evolution over the last 80 years, Ascensia, as it is known today, has a history of innovation in diabetes care.
  • Mary Puncochar, US Region Head, commented: "It's a real honor to be recognized at Joslin Diabetes Center's High Hopes Gala and we would like to congratulate all the other honorees.

Ascensia Diabetes Care Honored At Joslin Diabetes Center High Hopes "Virtual" Gala

Retrieved on: 
Monday, November 15, 2021
Ames Reflectance Meter, CGM, CONTOUR, Reading, No, Technology, BGM, Blood, Joslin, Joslin Diabetes Center, Partnership, History, Diabetes, Glucose meter, Foundation, Medical device

PARSIPPANY,N.J., Nov. 15, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR blood glucose monitoring (BGM) system portfolio and distributors of the Eversense continuous glucose monitoring (CGM) system, was named as an honoree at the Joslin Diabetes Center High Hopes Gala, to celebrate the 100th Anniversary of Insulin, held on November 13th.

Key Points: 
  • PARSIPPANY,N.J., Nov. 15, 2021 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, makers of CONTOUR blood glucose monitoring (BGM) system portfolio and distributors of the Eversense continuous glucose monitoring (CGM) system, was named as an honoree at the Joslin Diabetes Center High Hopes Gala, to celebrate the 100th Anniversary of Insulin, held on November 13th.
  • The event honored the top 100 people, groups, corporations and foundations that Joslin admire and appreciate for their impact on the diabetes community.
  • Throughout the organization's evolution over the last 80 years, Ascensia, as it is known today, has a history of innovation in diabetes care.
  • Mary Puncochar, US Region Head, commented: "It's a real honor to be recognized at Joslin Diabetes Center's High Hopes Gala and we would like to congratulate all the other honorees.

VIOLIFE® Plant Grants Awards $100K to Five Black-Owned Restaurants to Promote Plant-Based Eating in Their Local Communities

Retrieved on: 
Thursday, September 16, 2021
Dai, Linda, Restaurant, Program, Joslin, Education, Student, Lactose, Heart, Taste, Run, Veganism, RZA, Nut, Meal, Intention, Home market effect, Brummel & Brown, Semi-vegetarianism, Food, COVID-19, Cheese, Country Crock, Plant, Mark (given name), Hospital, Organization, Face, History, Acquisition, Woman, France Nuyen, Imperial, Fast food, Dairy product

This year's program aims to address the disproportionate challenges faced by Black-owned restaurants and communities, exacerbated by the COVID-19 pandemic.

Key Points: 
  • This year's program aims to address the disproportionate challenges faced by Black-owned restaurants and communities, exacerbated by the COVID-19 pandemic.
  • The 2021 Plant Grants program is the first year of a planned annual initiative.
  • Inspiring more people to eat plant-based is at the heart of the Plant Grants program.
  • The 2021 Plant Grants recipients share a passion for plant-based eating and have already started making a positive impact in their communities though their food.

Pool Corporation Announces Officer Updates and Welcomes New Corporate Controller

Retrieved on: 
Monday, July 19, 2021
Joslin, Business, Chief financial officers, Management, Leadership

As Vice President and Chief Financial Officer, Mrs. Hart will remain the Companys principal accounting officer and will also take on the role of Treasurer.

Key Points: 
  • As Vice President and Chief Financial Officer, Mrs. Hart will remain the Companys principal accounting officer and will also take on the role of Treasurer.
  • The Company's current Chief Financial Officer, Mark W. Joslin, will continue to serve as Senior Vice President until his retirement on October 1, 2021.
  • The Company also announced today that Walker Saik was hired to be the new Corporate Controller.
  • Pool Corporation is the worlds largest wholesale distributor of swimming pool and related backyard products.

Nemaura Medical Announces Presentation on its Licensed Why WAIT Program During the American Diabetes Association 81st Annual Scientific Sessions

Retrieved on: 
Wednesday, June 30, 2021
Articles, Health, Harvard Medical School, Joslin Diabetes Center, Telehealth, Joslin, Diabetes, Why Wait

The Why WAIT program is an award-winning 12-week program to help patients manage their weight and diabetes conditions.

Key Points: 
  • The Why WAIT program is an award-winning 12-week program to help patients manage their weight and diabetes conditions.
  • The Why WAIT program was developed by the Joslin Diabetes Center in Boston, MA and demonstrated long-term success.
  • Nemaura Medical Inc. licensed the Why WAIT mobile application from Healthimation to be included in its BEAT diabetes program.
  • The Why WAIT mobile application and telehealth were used in the virtual Why WAIT program, which was compared in the study to the in-person Why WAIT.

Pool Corporation To Present At The 44th Nasdaq Investor Conference

Retrieved on: 
Tuesday, June 8, 2021
Economy of New York City, NASDAQ, Joslin, Finance

COVINGTON, La., June 08, 2021 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Mark W. Joslin, Senior Vice President and Chief Financial Officer, and Melanie Housey Hart, Vice President and Chief Accounting Officer, will be participating in investor meetings at the 44th Nasdaq Investor Conference on Tuesday, June 15, 2021, and Thursday, June 17, 2021.

Key Points: 
  • COVINGTON, La., June 08, 2021 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Mark W. Joslin, Senior Vice President and Chief Financial Officer, and Melanie Housey Hart, Vice President and Chief Accounting Officer, will be participating in investor meetings at the 44th Nasdaq Investor Conference on Tuesday, June 15, 2021, and Thursday, June 17, 2021.
  • They will also be giving a virtual presentation on Thursday, June 17, 2021, at 8:30 AM Eastern Time.
  • Informational materials used during the conference will be posted on POOLCORPs website on the morning of the conference.
  • Pool Corporation is the worlds largest wholesale distributor of swimming pool and related backyard products.

Pool Corporation to Present at the Baird 2021 Virtual Global Consumer, Technology & Services Conference

Retrieved on: 
Wednesday, June 2, 2021
Joslin, NASDAQ, Fireside chats, The United States, Finance, 20th century in the United States

COVINGTON, La., June 02, 2021 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Peter D. Arvan, President and Chief Executive Officer, and Mark W. Joslin, Senior Vice President and Chief Financial Officer, will be participating in the Baird 2021 Virtual Global Consumer, Technology & Services Conference.

Key Points: 
  • COVINGTON, La., June 02, 2021 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Peter D. Arvan, President and Chief Executive Officer, and Mark W. Joslin, Senior Vice President and Chief Financial Officer, will be participating in the Baird 2021 Virtual Global Consumer, Technology & Services Conference.
  • The general session will occur on Wednesday, June 9, 2021, at 9:40 AM Eastern Time and will be in a fireside chat format consisting of a short presentation followed by Q&A.
  • Informational materials used during the conference will be posted on POOLCORPs website on the morning of the conference.
  • Pool Corporation is the worlds largest wholesale distributor of swimming pool and related backyard products.